NCT01801982View on ClinicalTrials.gov

A Non-Interventional Follow Up Study For Subjects Who Received Sildenafil for Persistent Pulmonary Hypertension of the Newborn (PPHN)

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Pulmonary Hypertension, Persistent, of the Newborn
Interventions
OTHER

non-interventional

non-interventional

Trial Locations (1)

WC1N 3JH

Great Ormond Street Hospital, Paediatric Intensive Care, London

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT01801982 - A Non-Interventional Follow Up Study For Subjects Who Received Sildenafil for Persistent Pulmonary Hypertension of the Newborn (PPHN) | Biotech Hunter | Biotech Hunter